Hospice News March 8, 2024
Jim Parker

Tightened regulation in the hospice space has led to longer, more stringent diligence processes when it comes to buying and selling provider companies.

The U.S. Centers for Medicare & Medicaid Services (CMS) has honed in on hospice program integrity through a number of new regulations, including some in the agency’s 2024 hospice final rule. The regulations focused on Medicare enrollment in an effort to stifle unethical or illegal activity in the space. Other provisions appeared in the 2024 home health final rule, which among other things prohibits the sale of a new hospice within 36 months.

Moreover, many hospices have been the subject of audits by various Medicare contractors, activity that shows no signs of slowing.

This means that potential...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: CMS, Govt Agencies, Mergers & Acquisitions / JV, Post-Acute Care, Provider, Regulations, Trends
Village Caregiving Expands Once Again, Bringing Its Footprint Into 22 States
New C-Suite Executives Tapped to Lead Hospices in 2025
Providence’s Joint Venture With Compassus Likely Delayed Amid Concerns About Patient Care And Rural Access
Joining Forces: 2024’s Hospice Investment, Consolidation Trends
Ensign Enters Oregon, Alaska with Providence Portfolio Acquisition

Share This Article